While data on tirzepatides long-term cardiovascular outcomes is still developing, early evidence points to comparable benefits, making both options valuable for patients looking to manage weight and enhance heart health simultaneously
Since it mimics a peptide already produced by the body, it's generally considered safe for short- or long-term use
"You have to provide them access to a registered dietitian, you have to provide them access to a gym membership, you have to provide them access to a fitness instructor or whatever network of services it is that you can provide to make sure that the change is in a lifestyle and not just in taking a medication once a week," he said
TrustScore This product has not yet been evaluated by our TrustScore system as we have insufficient data
Week 1: baseline disruption Most people begin GLP-1 therapy at the lowest available dose
Weight loss typically continues for 12 to 18 months before plateauing